Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

23/09/2020 STrengthening the Reporting Of Pharmacogenetic Studies: Development of the STROPS guideline 22/01/2020 PaCIR: A tool to enhance pharmacist patient care intervention reporting 11/10/2016 Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective 20/04/2016 Developing the Clarity and Openness in Reporting: E3-based (CORE) reference user manual for creation of clinical study reports in the era of clinical trial transparency 11/03/2016 Reporting guidelines for population pharmacokinetic analyses 04/03/2016 Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT 17/03/2015 Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement 17/09/2014 Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology 14/08/2013 Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials 05/07/2013 Authors’ Submission Toolkit: a practical guide to getting your research published

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More